V, G., T, G., EC, L., E, J., Q, D. C., P, F., . . . S, V. (2022). Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. The EMBO journal, 41(9), e110466. https://doi.org/10.15252/embj.2021110466
Chicago Style (17th ed.) CitationV, Gouirand, et al. "Ketogenic HMG-CoA Lyase and Its Product β-hydroxybutyrate Promote Pancreatic Cancer Progression." The EMBO Journal 41, no. 9 (2022): e110466. https://doi.org/10.15252/embj.2021110466.
MLA (9th ed.) CitationV, Gouirand, et al. "Ketogenic HMG-CoA Lyase and Its Product β-hydroxybutyrate Promote Pancreatic Cancer Progression." The EMBO Journal, vol. 41, no. 9, 2022, p. e110466, https://doi.org/10.15252/embj.2021110466.
Warning: These citations may not always be 100% accurate.